Shared Decision-Making Empowers Patients with Information and Options to Benefit Bone and Joint Care

December 8, 2020

Shared Decision-Making is a process of communication between the physician and a patient that incorporates a two-way exchange of information in which the physician, an expert in evidence, educates the patient on the risks, benefits, and alternatives to treatment advises the American Academy of Orthopedic Surgeons.

The patient, an expert in themselves, educates the physician on their values and preferences so the two parties can come to a mutual decision. Studies suggest that most patients prefer to share decisions with physicians rather than take on completely autonomous or passive roles.

Shared Decision-Making has been shown to:

  • Reduce decisional conflict (e.g., uncertainty over which course of action to take)
  • Increase patient knowledge
  • Improve health outcomes and increase patient satisfaction

“Shared decision-making is a partnership fueled by a discussion that should be initiated by the physician,” said Robert A. Probe, MD, FAAOS, orthopaedic surgeon at Baylor Scott & White Health, Temple, TX. “Our experience suggests that many orthopaedic surgeons lack an understanding of how to actually engage in SDM or received insufficient communications skills training in medical school and residency. While some physicians can naturally communicate and already incorporate SDM in patient care, there are still a lot who don’t. The goal of this review was to raise awareness and help the orthopaedic community and patients become more educated on the topic.”

Ideally, SDM begins with an invitation from the physician demonstrating their eagerness to engage in a shared decision process. However, Dr. Probe also encourages patients who sense that their perspective is not being fully considered, to bring these important considerations to the fore. Tactful transitions such as “Could we explore how your medical information fits into my life?” sends a clear message to the physician that there are other important considerations beyond what they already know. Once the data set for the decision is established, both parties embark on bringing their unique contributions to the conversation.

The patient can share their feelings about the surgery, providing a better understanding of their culture and lifestyle expectations. The physician can enhance the discussion by providing decision aids, a video, pamphlet, or web-based information that objectively provides patients with the risks and benefits of these treatment options. In order to maintain objectivity with evidence-based information, the International Patient Decision Aids Standards Collaboration and National Quality Forum have published criteria that should be considered when selecting aids to give to patients. Together, the patient and physician select the treatment plan that best aligns with the patient’s preferences.

“It’s important not to assume these discussions regularly occur, when in fact, a patient’s limited health literacy and cultural differences may stand in the way of SDM,” said Dr. Probe. “Decision aids, especially those written at various reading levels, can help reduce disparities in resource utilization among minorities, leading to a more informed conversation that takes into account cultural differences, religious beliefs and quality of life issues.”

Moving forward, Dr. Probe is optimistic that with increased awareness, orthopaedic surgeons can determine best practices for incorporating SDM into their workflows for patients who want to be involved in the decision-making process.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”